TNFα and IL-1β modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons - PubMed (original) (raw)
TNFα and IL-1β modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons
Amrita Datta Chaudhuri et al. Cell Death Dis. 2018.
Abstract
Astrocytes are known to be critical regulators of neuronal function. However, relatively few mediators of astrocyte to neuron communication have been identified. Recent advancements in the biology of extracellular vesicles have begun to implicate astrocyte derived extracellular vesicles (ADEV) as mediators of astrocyte to neuron communication, suggesting that alterations in the release and/or composition of ADEVs could influence gliotransmission. TNFα and IL-1β are key mediators of glial activation and neuronal damage, but the effects of these cytokines on the release or molecular composition of ADEVs is unknown. We found that ADEVs released in response to IL-1β (ADEV-IL-1β) and TNFα (ADEV-TNFα) were enriched with miRNAs that target proteins involved in neurotrophin signaling. We confirmed that miR-125a-5p and miR-16-5p (both enriched in ADEV-IL-1β and ADEV-TNFα) targeted NTKR3 and its downstream effector Bcl2. Downregulation of these targets in neurons was associated with reductions in dendritic growth, dendritic complexity, reduced spike rates, and burst activity. Molecular interference of miR-125a-5p and miR-16-5p prevented ADEV-IL-1β from reducing dendritic complexity, spike, and burst rates. These findings suggest that astrocytes respond to inflammatory challenge by modifying the miRNA cargo of ADEVs to diminish the activity of target neurons by regulating the translational expression of proteins controlling programs essential for synaptic stability and neuronal excitability.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Fig. 1. ADEV-ATP enhances dendritic arborization.
a Representative fluorescent images of MAP2 immunopositive hippocampal neurons (top panels) and Neurolucida dendrite tracings (bottom panels) following a 48 h exposure to the indicated concentrations of ADEV-ATP. Quantitative data show b dendritic complexity, c surface area, d dendritic length, e number of ends, f nodes, and g total dendrite number for the indicated concentrations of ADEV-ATP. Data are mean ± SEM of 15–20 neurons from three independent experiments. One-way ANOVA with Tukey’s post hoc comparisons. *p < 0.05, **p < 0.01, ***p < 0.001 compared to control
Fig. 2. ADEV-IL-1β and ADEV-TNFα dose-dependently reduce dendritic complexity.
a Representative fluorescent images of MAP2 immunopositive hippocampal neurons (top panels) and Neurolucida dendrite tracings (bottom panels) following a 48 h exposure to the indicated concentrations of ADEV-IL-1β. Quantitative data show (b) dendritic complexity, c surface area, d dendritic length, e number of ends, f nodes, and g total dendrite number for the indicated concentrations of ADEV-IL-1β. h Representative fluorescent images of MAP2 immunopositive hippocampal neurons (top panels) and neurite tracings (bottom panels) following a 48 h exposure to the indicated concentrations of ADEV-IL-1β. Quantitative data show i dendritic complexity, j surface area, k dendritic length, l number of ends, m nodes, and n total dendrite number for the indicated concentrations of ADEV-IL-1β. Data are mean ± SEM of 15–20 neurons from three independent experiments. One-way ANOVA followed by Tukey’s post hoc comparisons. #p < 0.05, ##p < 0.01, ###p < 0.001 compared to control
Fig. 3. Stimulus-depended enrichment of miRNA cargo in ADEVs.
a Heatmap and hierarchical clustering showing relative levels for microRNAs enriched >1.5-fold in ADEVs shed in response to the indicated treatment conditions compared with ADEV-CR. b qRT-PCR validation of the miRNAs most enriched in ADEV-IL-1β. c qRT-PCR validation of the miRNAs most enriched in ADEV-TNFα. d qRT-PCR of the microRNAs most enriched in astrocyte ADEV-ATP. e qRT-PCR showing levels of the indicated miRNAs in cultured astrocytes following treatment with ATP (10 μM), IL-1β or TNFα (200 ng/ml) for 2 h. Data are mean ± SEM of n = 3 independent experiments. One-way ANOVA with Tukey’s post hoc comparisons. *p < 0.05, **p < 0.01, ***p < 0.001 compared with CR
Fig. 4. Bioinformatic interrogation of miRNAs enriched in ADEV-IL-1β and ADEV-TNFα identified several neuronal-specific pathways.
a Pathway analysis of predicted miRNA targets enriched in ADEV-IL-1β using DIANA miRPATH. b Pathway analysis of predicted miRNA targets enriched in ADEV-TNFα using DIANA miRPATH. Heat maps depict levels of miRNA enrichment for the indicated signaling pathways. Darker colors (orange to red) indicate more enrichment of predicted microRNA targets belonging to the corresponding pathway. Several predicted pathways were associated with neurite outgrowth, dopamine and glutamatergic synapses, long-term potentiation, long-term depression, and neurotrophin signaling (shown in red)
Fig. 5. MiR-125a-5p and miR-16-5p target NTRK3 and Bcl2.
a Schematic diagram of the neurotrophin-signaling pathway. The mRNAs in red text and yellow highlight are predicted targets of at least two miRNAs (miR-125a-5p and miR-16-5p) enriched in ADEV-TNFα, or ADEV-IL-1β. The mRNAs in magenta text are predicted targets of 1 miRNA enriched in ADEV-TNFα, or ADEV-IL-1β. b Representative western blot for NTRK3 and Bcl2 in primary neurons treated with ADEV-CR or ADEV-IL-1β at the indicated particle dose. Densitometry quantitation of (c) NTRK3, and (d) Bcl2 levels normalized to β-actin. Schematic diagrams show (e) miR-125a-5p binding site on NTRK3 3′-UTR, f miR-125a-5p binding site on BCL2 3′-UTR, g miR-16-5p binding site on NTRK3 3’UTR, and h miR-16-5p binding site on BCL2 3′-UTR. i 3′-UTR luciferase reporter assay showing functional binding of miR-125a-5p to the 3′-UTR of NTRK3 and Bcl2. j 3′-UTR luciferase reporter assay showing functional binding of miR-16-5p to the 3′-UTR of NTRK3 and Bcl2. k 3′-UTR luciferase reporter assay in cells transfected with NTRK3 3′-UTR followed by treatment with ADEV-CR, ADEV-ATP or ADEV-IL-1β at the indicated ADEV dose. Data are mean ± SEM of a minimum n = 3 independent experiments per condition. One-way ANOVA with Tukey’s post hoc comparisons. #p < 0.05, ##p < 0.01, ###p < 0.001 compared to control
Fig. 6. Molecular interference of miR-125a-5p and miR-16-5p prevents ADEV-IL-1β from reducing NTRK3 and BCl2 expression.
a Representative western blot showing NTKR3 and Bcl2 protein expression in neurons 24 h following treatment with ADEV-CR or ADEV-IL-1β alone or in combination with antisense oligonucleotide inhibitors for miR-125 and miR-16 (20 pmole each; Combined In). Scrambled oligonucleotide inhibitors were used as a control (Scr In). Quantitative densitometry analysis of (b) NTRK3, and (c) Bcl2 for the indicated treatment conditions. d Representative western blot showing NTKR3 and Bcl2 protein expression in neurons 24 h following treatment with ADEV-CR or ADEV-IL-1β alone or in combination with antisense oligonucleotide inhibitors either miR-1 25 or miR-16 alone or in combination (20 pmole each; Combined In). Scrambled oligonucleotide inhibitors were used as a control (Scr In). Quantitative densitometry analysis of (e) NTRK3, and (f) Bcl2 for the indicated treatment conditions. Data are mean ± SEM of n = 3 independent experiments. One-way ANOVA with Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 increased compared to no treatment (NT), #p < 0.05, ###p < 0.001 decreased compared with NT
Fig. 7. Molecular interference of miR-125a-5p and miR-16-5p prevents ADEV-IL-1β from reducing dendritic arborization.
a Representative fluorescent images of MAP2 immunopositive hippocampal neurons (top panels) and Neurolucida dendrite tracings (bottom panels) following a 48 h exposure to the indicated treatment conditions. Quantitative data show (b) dendritic complexity, c surface area, d dendritic length, e number of ends, f nodes, and g total dendrite number for the indicated treatment conditions. ADEV-IL-1β particle dose was 50 ADEVs/cell, and antisense oligonucleotide inhibitors for miR-125 and miR-16 were used at 20 pmole. Data are mean ± SEM for the indicated treatment conditions. One-way ANOVA followed by Tukey’s post hoc test. *p < 0.05, **p < 0.01, ***p < 0.001 increased compared to NT. #p < 0.05, ##p < 0.01, ###p < 0.001 decreased compared to NT
Fig. 8. ADEV-IL-1β reduces neuronal activity but not connectivity.
a Representative recording of population spikes (each purple vertical line), and bursts (purple clusters with >4 spikes/s) from an individual electrode of a multichannel electrode array. Representative tracings show averages of spikes/second/electrode, and associated scatter plots show quantitation of spike and burst rates for (b–e) Control, (f–i) ADEV-IL-1β (particle dose of 50 ADEVs/cell), (j–m) ADEV-IL-1β+ Scrambled oligonucleotide (Scr In, 20 pmole), and (n–q) ADEV-IL-1β+ oligonucleotide inhibitors for miR-125 and miR-16 (Combined In, 20 pmole each). Data are mean ± SEM. Paired _t_-tests were performed to compare spike and burst rate of each electrode before and after treatment. ***p < 0.001 increased compared to baseline and ###p < 0.001 decreased compared to baseline
Similar articles
- Stimulus-dependent modifications in astrocyte-derived extracellular vesicle cargo regulate neuronal excitability.
Datta Chaudhuri A, Dasgheyb RM, DeVine LR, Bi H, Cole RN, Haughey NJ. Datta Chaudhuri A, et al. Glia. 2020 Jan;68(1):128-144. doi: 10.1002/glia.23708. Epub 2019 Aug 30. Glia. 2020. PMID: 31469478 - iPSC-derived healthy human astrocytes selectively load miRNAs targeting neuronal genes into extracellular vesicles.
Gordillo-Sampedro S, Antounians L, Wei W, Mufteev M, Lendemeijer B, Kushner SA, de Vrij FMS, Zani A, Ellis J. Gordillo-Sampedro S, et al. Mol Cell Neurosci. 2024 Jun;129:103933. doi: 10.1016/j.mcn.2024.103933. Epub 2024 Apr 23. Mol Cell Neurosci. 2024. PMID: 38663691 - Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP.
Li Z, Moniruzzaman M, Dastgheyb RM, Yoo SW, Wang M, Hao H, Liu J, Casaccia P, Nogueras-Ortiz C, Kapogiannis D, Slusher BS, Haughey NJ. Li Z, et al. J Extracell Vesicles. 2020 Dec;10(2):e12035. doi: 10.1002/jev2.12035. Epub 2020 Dec 31. J Extracell Vesicles. 2020. PMID: 33408815 Free PMC article. - Extracellular Vesicles Derived From Neural Stem Cells, Astrocytes, and Microglia as Therapeutics for Easing TBI-Induced Brain Dysfunction.
Hering C, Shetty AK. Hering C, et al. Stem Cells Transl Med. 2023 Mar 17;12(3):140-153. doi: 10.1093/stcltm/szad004. Stem Cells Transl Med. 2023. PMID: 36847078 Free PMC article. Review. - Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.
Upadhya R, Zingg W, Shetty S, Shetty AK. Upadhya R, et al. J Control Release. 2020 Jul 10;323:225-239. doi: 10.1016/j.jconrel.2020.04.017. Epub 2020 Apr 11. J Control Release. 2020. PMID: 32289328 Free PMC article. Review.
Cited by
- Extracellular Vesicle-Mediated Neuron-Glia Communications in the Central Nervous System.
Ikezu T, Yang Y, Verderio C, Krämer-Albers EM. Ikezu T, et al. J Neurosci. 2024 Oct 2;44(40):e1170242024. doi: 10.1523/JNEUROSCI.1170-24.2024. J Neurosci. 2024. PMID: 39358029 Review. - Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions.
Choi HK, Chen M, Goldston LL, Lee KB. Choi HK, et al. Nano Converg. 2024 May 13;11(1):19. doi: 10.1186/s40580-024-00426-5. Nano Converg. 2024. PMID: 38739358 Free PMC article. Review. - Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.
Laketa D, Lavrnja I. Laketa D, et al. Mol Neurobiol. 2024 Oct;61(10):8361-8386. doi: 10.1007/s12035-024-04104-9. Epub 2024 Mar 18. Mol Neurobiol. 2024. PMID: 38499905 Review. - Transplantation of Neural Stem Cells Loaded in an IGF-1 Bioactive Supramolecular Nanofiber Hydrogel for the Effective Treatment of Spinal Cord Injury.
Song P, Han T, Wu Z, Fang H, Liu Y, Ying W, Wang X, Shen C. Song P, et al. Adv Sci (Weinh). 2024 May;11(17):e2306577. doi: 10.1002/advs.202306577. Epub 2024 Mar 5. Adv Sci (Weinh). 2024. PMID: 38441409 Free PMC article. - Acute Genetic Damage Induced by Ethanol and Corticosterone Seems to Modulate Hippocampal Astrocyte Signaling.
Reyes-Ábalos AL, Álvarez-Zabaleta M, Olivera-Bravo S, Di Tomaso MV. Reyes-Ábalos AL, et al. Int J Cell Biol. 2024 Feb 26;2024:5524487. doi: 10.1155/2024/5524487. eCollection 2024. Int J Cell Biol. 2024. PMID: 38439918 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG057420/AG/NIA NIH HHS/United States
- R01 DA040390/DA/NIDA NIH HHS/United States
- P30 MH075673/MH/NIMH NIH HHS/United States
- R01 MH077542/MH/NIMH NIH HHS/United States
- R01 MH110246/MH/NIMH NIH HHS/United States
- R01 DA040385/DA/NIDA NIH HHS/United States
- R25 MH080661/MH/NIMH NIH HHS/United States
- P01 MH105280/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources